Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest Memorial Sloan–Kettering Cancer Center Stories

2013-06-03 12:37:18

The combination of the immunotherapy drug ipilimumab and the investigational antibody drug nivolumab led to long-lasting tumor shrinkage in more than half of patients with metastatic melanoma, according to results from a Phase I trial simultaneously published online on Sunday, June 2, in The New England Journal of Medicine and presented by Memorial Sloan-Kettering Cancer Center researchers at the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO). Several patients...

2013-05-30 23:02:21

The Society for Translational Oncology (STO) is pleased to announce that Professor Patrick G. Johnston, M.D., Ph.D, Dean of the School of Medicine, Dentistry & Biomedical Sciences, Queen´s University Belfast, Northern Ireland, has been named recipient of the 2013 Bob Pinedo Cancer Care Prize. Durham, NC (PRWEB) May 30, 2013 The Society for Translational Oncology (STO) is pleased to announce that Professor Patrick G. Johnston, M.D., Ph.D, Dean of the School of Medicine, Dentistry...

2013-05-09 23:45:40

The Cancer Research Institute (CRI) declares June “Cancer Immunotherapy Awareness Month” to increase awareness of cancer immunotherapy, a new class of cancer treatment that mobilizes the immune system to fight the disease and represents the most immediate hope for curing patients with any type of cancer. The month will feature educational webinars offered free to the public from top experts in cancer immunotherapy, and a Wear White for a Cure Day on June 7. New York, NY (PRWEB)...

2013-04-04 16:24:17

XF Technology Brings New Perspective to Cancer Metabolism BILLERICA, Mass., April 4, 2013 /PRNewswire/ -- Seahorse Bioscience, the world leader in instruments and assay kits for measuring cell metabolism announces travel award recipients who will present data generated using XF technology at the American Association of Cancer Research (AACR) Annual Meeting, in Washington, DC, April 6-10, 2013. Kate M. Bailey, Ph.D., candidate in the lab of Robert J. Gillies, Ph.D., at the H. Lee...

2013-03-11 12:24:46

Memorial Sloan-Kettering Cancer Center's national fundraising event has raised more than $31 million for rare cancer research since 2007 with founding partner, Equinox NEW YORK, March 11, 2013 /PRNewswire/ -- More than 12,000 cyclers gathered in ten cities across the country in February and early March to raise more than $13.8 million to support rare cancer research at Memorial Sloan-Kettering Cancer Center. The events took place at Equinox clubs in New York City; Los Angeles; San...

2013-02-19 12:31:11

NEW YORK, Feb. 19, 2013 /PRNewswire/ -- In July 2013, Walk the Walk will bring The MoonWalk marathon from the United Kingdom to America for the first time to raise awareness and funds for breast cancer causes. At 10 p.m., on July 20, 2013, thousands of women and men will Power Walk through the city wearing brightly decorated bras to inspire and encourage others to get fit, have fun, and raise money for breast cancer charities in New York. Presented by Empire BlueCross BlueShield, the...

2013-02-08 12:23:17

NEW YORK, Feb. 8, 2013 /PRNewswire/ -- IBM (NYSE: IBM), WellPoint, Inc. (NYSE: WLP) and Memorial Sloan-Kettering Cancer Center today unveiled the first commercially developed Watson-based cognitive computing breakthroughs. These innovations stand alone to help transform the quality and speed of care delivered to patients through individualized, evidence based medicine. (Photo: http://photos.prnewswire.com/prnh/20130208/NY57025 )(Logo: http://photos.prnewswire.com/prnh/20090416/IBMLOGO )...

2013-01-22 08:27:53

BEVERLY HILLS, Calif., Jan. 22, 2013 /PRNewswire/ -- Dr. Andrew Ordon, Board Certified Plastic Surgeon and co-host of the daytime talk show, The Doctors, and his surgical group at the Rox Center in Beverly Hills are announcing the founding of the Rox Cancer Center. This private medical corporation is focused around Dr. Travis Kidner who is a formally trained surgical oncologist and Board Certified General Surgeon. "Dr. Kidner brings expertise and experience from Memorial Sloan Kettering and...

2012-10-24 07:29:54

NEW YORK, Oct. 24, 2012 /PRNewswire/ -- Actinium Pharmaceuticals, Inc., (API), a private biopharmaceutical company that develops innovative targeted radio-immunotherapeutics, announced that the poster summarizing the results for Phase I study of Actimab-A, its antibody directed alpha emitter drug candidate, has won a first place poster presentation award at the 8th Annual Hematologic Malignancies 2012 Conference held in Houston, TX, from October 10-14. The award was presented to Dr. Joseph...

2012-10-10 11:25:18

NEW YORK, Oct. 10, 2012 /PRNewswire/ -- Actinium Pharmaceuticals, Inc., (API), a privately held biopharmaceutical company that develops innovative targeted radio-immunotherapeutics, announced the presentation of a scientific poster summarizing the results for a Phase I study of Actimab-A, its antibody directed alpha emitter drug candidate for the front line treatment of acute myeloid leukemia in older patients. Actimab-A was evaluated in a Phase I dose escalating trial at Memorial...